Concepedia

Matthew Kraman

MK

Statistics

Publications

16

Citations

4.6K

H-Index

14

Active since

1996

Affiliations

University of Cambridge(Current)

Wellcome Trust

F-star (United Kingdom)

Center for Biologics Evaluation and Research

Wellcome/MRC Cambridge Stem Cell Institute

Matthew Kraman is an author at University of Cambridge specializing in immunology, oncology, and cancer immunotherapy.

ORCID

Publications per year

1996–2020

16

Publications

16

Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer

Christine Feig, James O. Jones, Matthew Kraman et al. · Proceedings of the National Academy of Sciences · 2013 · 2K citations

, , +17

Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α

Matthew Kraman, Paul Bambrough, James N. Arnold et al. · Science · 2010 · 1.1K citations

, , +17

Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia

Edward W. Roberts, Andrew Deonarine, James O. Jones et al. · The Journal of Experimental Medicine · 2013 · 410 citations · Full text

, , +16

A common region of 10p deleted in DiGeorge and velocardiofacial syndromes

S. C. M. Daw, Catherine Taylor, Matthew Kraman et al. · Nature Genetics · 1996 · 219 citations

, , +6

Tumoral Immune Suppression by Macrophages Expressing Fibroblast Activation Protein-α and Heme Oxygenase-1

James N. Arnold, Łukasz Magiera, Matthew Kraman et al. · Cancer Immunology Research · 2013 · 167 citations · Full text

, , +17

1–5 of 16